| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.091 | 0.003 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.096 | 0.003 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |